Invention Grant
- Patent Title: System and method for determining Cetuximab sensitivity on gastric cancer
-
Application No.: US16499275Application Date: 2018-03-28
-
Publication No.: US11459618B2Publication Date: 2022-10-04
- Inventor: Binchen Mao , Sheng Guo , Henry Qixiang Li
- Applicant: CROWN BIOSCIENCE, INC. (TAICANG)
- Applicant Address: CN Jiangsu
- Assignee: CROWN BIOSCIENCE, INC. (TAICANG)
- Current Assignee: CROWN BIOSCIENCE, INC. (TAICANG)
- Current Assignee Address: CN Jiangsu
- Agency: Jun He Law Offices P.C.
- Agent James J. Zhu
- International Application: PCT/CN2018/080890 WO 20180328
- International Announcement: WO2018/177325 WO 20181004
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; C12Q1/6886 ; G16B40/00 ; G16B40/20 ; G16B50/50
Abstract:
A panel of gene expression markers for gastric cancer patient treated or to be treated by cetuximab is provided. Methods and compositions are also provided, e.g., kits, for evaluating gene expression levels of the markers and methods of using such gene expression levels to predict a gastric cancer patient's response to cetuximab.
Public/Granted literature
- US20200071769A1 SYSTEM AND METHOD FOR DETERMINING CETUXIMAB SENSITIVITY ON GASTRIC CANCER Public/Granted day:2020-03-05
Information query
